Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2021 3
2022 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
Digitally enabled hemovigilance allows real time response to transfusion reactions.
Villamin C, Bates T, Mescher B, Benitez S, Martinez F, Knopfelmacher A, Correa Medina M, Klein K, Dasgupta A, Jaffray DA, Porter C, Tereffe W, Gallardo L, Kelley J. Villamin C, et al. Among authors: knopfelmacher a. Transfusion. 2022 May;62(5):1010-1018. doi: 10.1111/trf.16882. Epub 2022 Apr 20. Transfusion. 2022. PMID: 35442519
High Levels of Common Cold Coronavirus Antibodies in Convalescent Plasma Are Associated With Improved Survival in COVID-19 Patients.
Greenbaum U, Klein K, Martinez F, Song J, Thall PF, Ramdial JL, Knape C, Aung FM, Scroggins J, Knopfelmacher A, Mulanovich V, Borjan J, Adachi J, Muthu M, Leung C, Medina MC, Champlin R, Olson A, Alousi A, Rezvani K, Shpall EJ. Greenbaum U, et al. Among authors: knopfelmacher a. Front Immunol. 2021 Apr 28;12:675679. doi: 10.3389/fimmu.2021.675679. eCollection 2021. Front Immunol. 2021. PMID: 33995420 Free PMC article. Clinical Trial.
High levels of common cold coronavirus antibodies in convalescent plasma are associated with improved survival in COVID-19 patients.
Greenbaum U, Klein K, Martinez F, Song J, Thall PF, Ramdial JL, Knape C, Aung FM, Scroggins J, Knopfelmacher A, Mulanovich V, Borjan J, Adachi J, Muthu M, Leung C, Medina MC, Champlin R, Olson A, Alousi A, Rezvani K, Shpall EJ. Greenbaum U, et al. Among authors: knopfelmacher a. medRxiv [Preprint]. 2021 Mar 10:2021.03.08.21252775. doi: 10.1101/2021.03.08.21252775. medRxiv. 2021. Update in: Front Immunol. 2021 Apr 28;12:675679. doi: 10.3389/fimmu.2021.675679. PMID: 33758890 Free PMC article. Updated. Preprint.
Trend towards reduction of transfusion reactions using prestorage leukocyte-reduced and pooled whole blood-derived platelets and cost savings compared with poststorage whole blood-derived random platelets as evidenced by real-time hemovigilance.
Park N, Correa Medina M, Martinez F, Throssel M, Dasgupta A, Knopfelmacher A, Villamin C, Rivas S, Tomczak N, Garg S, Layton L, Klein K. Park N, et al. Among authors: knopfelmacher a. Lab Med. 2024 May 2;55(3):251-254. doi: 10.1093/labmed/lmad106. Lab Med. 2024. PMID: 38175635